Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.870
+0.080 (4.47%)
At close: Oct 4, 2024, 4:00 PM
1.852
-0.018 (-0.96%)
After-hours: Oct 4, 2024, 6:37 PM EDT

Caribou Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
33.1134.4813.859.612.365.79
Revenue Growth (YoY)
132.34%148.91%44.31%-22.35%113.56%-
Cost of Revenue
129.13112.0882.2352.2634.4323.64
Gross Profit
-96.02-77.6-68.38-42.66-22.06-17.85
Selling, General & Admin
45.5638.4638.0224.3214.0616.46
Operating Expenses
45.5638.4638.0224.3214.0616.46
Operating Income
-141.58-116.06-106.4-66.98-36.12-34.31
Interest Expense
-----0.02-0
Interest & Investment Income
2.7---0.241.05
Other Non Operating Income (Expenses)
15.7514.197.18-1.210.51-
EBT Excluding Unusual Items
-123.13-101.87-99.22-68.19-35.39-33.26
Gain (Loss) on Sale of Investments
-0.12-0.01-0.13--0.732.29
Other Unusual Items
---1.58--
Pretax Income
-123.25-101.88-99.35-66.6-36.13-30.97
Income Tax Expense
0.190.190.070.32-1.82-7.54
Net Income
-123.44-102.07-99.42-66.92-34.31-23.43
Net Income to Common
-123.44-102.07-99.42-66.92-34.31-23.43
Shares Outstanding (Basic)
8874613298
Shares Outstanding (Diluted)
8874613298
Shares Change (YoY)
44.07%21.39%92.02%270.47%2.05%-
EPS (Basic)
-1.40-1.38-1.64-2.11-4.01-2.80
EPS (Diluted)
-1.40-1.38-1.64-2.11-4.01-2.80
Free Cash Flow
-130.95-104.9-97.42-34.64-33.53-32.89
Free Cash Flow Per Share
-1.49-1.42-1.60-1.09-3.92-3.93
Gross Margin
-289.97%-225.07%---178.50%-
Operating Margin
-427.56%-336.63%-768.17%-697.84%-292.24%-592.69%
Profit Margin
-372.78%-296.05%-717.79%-697.26%-277.55%-404.82%
Free Cash Flow Margin
-395.48%-304.27%-703.34%-360.91%-271.27%-568.24%
EBITDA
-137.69-112.53-104.78-66-35.22-33.55
EBITDA Margin
-----284.96%-
D&A For EBITDA
3.893.531.620.980.90.75
EBIT
-141.58-116.06-106.4-66.98-36.12-34.31
EBIT Margin
-----292.24%-
Source: S&P Capital IQ. Standard template. Financial Sources.